Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy

BACKGROUND: Studies have partly demonstrated the clinical validity of Ki-67 as a predictive marker in the neoadjuvant setting, but the question of the best cut-off points as well as the importance of this marker as a prognostic factor in partial responder/non-responder groups remains uncertain. METH...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diagn Pathol
Main Authors: Ács, Balázs, Zámbó, Veronika, Vízkeleti, Laura, Szász, A. Marcell, Madaras, Lilla, Szentmártoni, Gyöngyvér, Tőkés, Tímea, Molnár, Béla Á., Molnár, István Artúr, Vári-Kakas, Stefan, Kulka, Janina, Tőkés, Anna-Mária
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5320658/
https://ncbi.nlm.nih.gov/pubmed/28222768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13000-017-0608-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados